Malcolm Hoenlein is Director of Fortress Biotech, Inc.. Currently has a direct ownership of 39,042 shares of FBIO, which is worth approximately $70,275. The most recent transaction as insider was on Jan 01, 2024, when has been sold 3,333 shares (Common Stock, par value $0.001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39K
0% 3M change
92.71% 12M change
Total Value Held $70,275

Malcolm Hoenlein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2024
BUY
Grant, award, or other acquisition
-
3,333 Added 7.87%
39,042 Common Stock, par valu...
Jan 01 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 8.54%
535,636 Common Stock, par valu...
Jan 01 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 9.33%
485,636 Common Stock
Nov 16 2021
BUY
Other acquisition or disposition
-
230 Added 0.05%
435,636 Common Stock
Sep 30 2021
BUY
Other acquisition or disposition
-
406 Added 0.09%
435,406 Common Stock
Jan 01 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 10.31%
435,000 Common Stock
MH

Malcolm Hoenlein

Director
New York, NY

Track Institutional and Insider Activities on FBIO

Follow Fortress Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBIO shares.

Notify only if

Insider Trading

Get notified when an Fortress Biotech, Inc. insider buys or sells FBIO shares.

Notify only if

News

Receive news related to Fortress Biotech, Inc.

Track Activities on FBIO